ASSUNTA SANDOR: Open Payments
NPI 1578607727 · NORTH HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,273 in 76 payments from 16 companies in 2025. Trend: 2023 $280 · 2024 $802 · 2025 $1,273
Food & beverage: $1,273
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $333 |
| AstraZeneca Pharmaceuticals LP | 13 | $321 |
| Indivior Inc. | 5 | $144 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Alkermes, Inc. | 3 | $68 |
| Novo Nordisk Inc | 2 | $47 |
| Lilly USA, LLC | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Braeburn Inc. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
Products named: VRAYLAR, BREZTRI, SUBLOCADE, TRELEGY ELLIPTA, AIRSUPRA, VIVITROL, QULIPTA, Wegovy.
Industry payments across CT — which companies pay providers there.
